hims novo nordisk - Search News

News

Hims & Hers stock plunges

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

Insider on MSN · 2d

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

Yahoo Finance · 4h

Hims & Hers Health (NYSE:HIMS) Faces Class Action After Partnership Termination With Novo Nordisk

Hims & Hers Health (NYSE:HIMS) has experienced a tumultuous quarter, marked by Novo Nordisk's termination of their collaboration after allegations of unsafe practices, resulting in a 35% drop in the company's share price.

2hon MSN

Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, ...

2d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

3d

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its ...

3don MSN

Novo Nordisk shares fall as obesity pipeline faces investor scrutiny

Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results